Cargando…

Buying Time: The AMR Action Fund and the State of Antibiotic Development in the United States 2020

Antimicrobial resistance is a pressing global threat, but companies developing antibiotics are failing. Large pharmaceutical companies recently created the AMR Action Fund, which will invest $1 billion in small antibiotic development companies. To understand the state of antibiotic development in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clancy, Cornelius J, Nguyen, M Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652093/ https://www.ncbi.nlm.nih.gov/pubmed/33209952 http://dx.doi.org/10.1093/ofid/ofaa464

Ejemplares similares

Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020
por: Buehrle, Deanna J., et al.
Publicado: (2021)

Emergence of Arboviruses in the United States: The Boom and Bust of Funding, Innovation, and Capacity
por: Kading, Rebekah C., et al.
Publicado: (2020)

Physician‐scientists in the United States at 2020: Trends and concerns
por: Garrison, Howard H., et al.
Publicado: (2022)

Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
por: Kanan, Mohammed, et al.
Publicado: (2023)

Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020)

Foundational Collective Actions for Achieving Agile High-Quality Primary Care in the United States
por: Reiss-Brennan, Brenda, et al.
Publicado: (2023)

779. Impact of updated IDSA practice guidelines on the treatment of Clostridium difficile infections in the United States
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Europe's ‘Horizon 2020’ science funding programme: how is it shaping up?
por: Galsworthy, Michael, et al.
Publicado: (2013)

COVID-19 and the current state of palliative care in the United States
por: Sina-Odunsi, Ayobami Jadesola, et al.
Publicado: (2022)

A First Draft of the History of Treating Coronavirus Disease 2019: Use of Repurposed Medications in United States Hospitals
por: Clancy, Cornelius J, et al.
Publicado: (2020)

Norovirus Disease in the United States
por: Hall, Aron J., et al.
Publicado: (2013)

Nordic Vets against AMR—An Initiative to Share and Promote Good Practices in the Nordic–Baltic Region
por: Sternberg-Lewerin, Susanna, et al.
Publicado: (2022)

Environmental surveillance of antimicrobial resistance (AMR), perspectives from a national environmental regulator in 2023
por: Hart, Alwyn, et al.
Publicado: (2023)

Institutional Open Access Funds: Now Is the Time
por: Eckman, Charles D., et al.
Publicado: (2010)

Mounting antiscience aggression in the United States
por: Hotez, Peter J.
Publicado: (2021)

No time to lower the guard on AMR
por: Devi, Sharmila
Publicado: (2020)

Making AMR history: a call to action
por: Ghebreyesus, Tedros Adhanom
Publicado: (2019)

The changing risk and burden of wildfire in the United States
por: Burke, Marshall, et al.
Publicado: (2021)

Comparison of Lyme Disease in the United States and Europe
por: Marques, Adriana R., et al.
Publicado: (2021)

Considering Sun Safety Policies in the United States
por: Mirza, Fatima N., et al.
Publicado: (2023)

The dawn of repurposing vitamins as potential novel antimicrobial agents: A call for global emergency response amidst AMR crisis
por: Max, Baraka L., et al.
Publicado: (2023)

Epidemiology of companion animal AMR in the United States of America: filling a gap in the one health approach
por: Sobkowich, Kurtis E., et al.
Publicado: (2023)

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective
por: Khurana, Surender
Publicado: (2018)

What motivates consumers to buy organic foods? Results of an empirical study in the United States
por: Gundala, Raghava R., et al.
Publicado: (2021)

Health Status of Visitors and Temporary Residents, United States
por: Yanni, Emad A., et al.
Publicado: (2009)

Salmonella Enteritidis Infections, United States, 1985–1999
por: Patrick, Mary E., et al.
Publicado: (2004)

Regulatory Status of Cannabidiol in the United States: A Perspective
por: Corroon, Jamie, et al.
Publicado: (2018)

Recognize fish as food in policy discourse and development funding
por: Bennett, Abigail, et al.
Publicado: (2021)

Proximate and ultimate causes of the bactericidal action of antibiotics
por: Baquero, Fernando, et al.
Publicado: (2020)

History of Mosquitoborne Diseases in the United States and Implications for New Pathogens
por: Moreno-Madriñán, Max J., et al.
Publicado: (2018)

The future of health professions education: Emerging trends in the United States
por: Thibault, George E.
Publicado: (2020)

The 25th Anniversary of Laser Vision Correction in the United States
por: Joffe, Stephen N
Publicado: (2021)

Financing Approaches to Social Prescribing Programs in England and the United States
por: SANDHU, SAHIL, et al.
Publicado: (2022)

Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities
por: McKenna, Lindsay, et al.
Publicado: (2022)

Abortion Surveillance — United States, 2020
por: Kortsmit, Katherine, et al.
Publicado: (2022)

Tobacco Product Use Among Adults — United States, 2020
por: Cornelius, Monica E., et al.
Publicado: (2022)

Risk of Importing Zoonotic Diseases through Wildlife Trade, United States
por: Pavlin, Boris I., et al.
Publicado: (2009)

Current status of advanced gastrointestinal endoscopy training fellowships in the United States
por: Heller, Stephen J, et al.
Publicado: (2011)

Early HIV Infection in the United States: A Virus's Eye View
por: Hallett, Timothy B.
Publicado: (2013)

Dietary supplements quality analysis tools from the United States Pharmacopeia
por: Sarma, Nandakumara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_77d5tmi92ra1cmrvo58jhbl9f2